PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting

Table 1

Temporal changes of crucial clinical parameters in patients with (HF) and without heart failure (NHF).

	HF				NHF
	1 month	1 year	2 years		1 month	1 year	2 years
NT-proBNP ng/mL (±SD)	647.6 (±410.2)	414.8 (±401.5)	423.0 (±453.5)	0.0001	221.9 (±97.9)	205.1 (±215.7)	236.4 (±238.0)	0.25
6MWT m (±SD)	369.7 (±99.7)	465.9 (±107.9)	438.7 (±128.1)	0.00002	444.9 (±53.3)	500.2 (±77.9)	489.5 (±107.8)	0.054
LVEF < 40%, (%)	12 (14%)	16 (24%)	14 (18%)	0.03	0 (0%)	2 (3%)	0 (0%)	0.9
PPAR gamma Ao, (±SD)	1.065 (±0.053)			NS	1.054 (±0.077)			NS
PPAR gamma LV, (±SD)	1.079 (±0.051)			NS	1.076 (±0.051)			NS